PHOENIX, AZ AND NEWPORT BEACH, CA / ACCESS Newswire / October 1, 2026 / Enyrgy Inc. has appointed Paul Sanchez to the Company's Financial Advisory Council, adding capital markets and family office depth and experience to the Council.

Mr. Sanchez will advise on financial planning and capital strategy. He joins Enyrgy, a company carrying a product return rate under 1 percent against an industry average of 5 to 10 percent, on a user base built without paid advertising.

Mr. Sanchez is a partner at Terra Rossa Family Office, a multi-family office platform serving high-net-worth families on wealth preservation and generational planning. He is also the founder and manager of The Zenith Fund, a hedge fund built on systematic trading strategies. He also works with an international trade desk supporting cross-border transactions.

Previously he spent 30 years as an executive recruiter, placing C-level executives at large public and private companies worldwide.

"We reached 600 users in five countries without buying a single advertisement," said Brian Cameron, CFO of Enyrgy. "A number like that deserves scrutiny before it gets celebrated. Mr. Sanchez advises families on capital they intend to hold for generations, which is a longer horizon than most people bring to a young company. We asked him to look at ours with that horizon in mind."

About Enyrgy Inc.

Enyrgy Inc. is a private health technology company in Phoenix, Arizona. Its Enyrgy Vitamin D Primal Light Platform emits over 90 percent UVB and under 10 percent UVA, verified by an independent laboratory, the inverse of natural sunlight's roughly 95 percent UVA. A session runs two to four minutes and supports vitamin D synthesis, nitric oxide release and serotonin production. The app calculates each user's dose from their skin type and ends the session automatically.

Efficacy, safety and usability are the three tenets the platform is built on, in that order, and the company treats efficacy as something to keep testing rather than something already settled. Larger trials are in development.

The platform has completed more than 25,000 sessions with a clean safety record, across more than 600 users in five countries. Enyrgy has never run paid advertising.

The return rate is under 1 percent, against an industry average of 5 to 10 percent, and the units are built in Phoenix. Dr. Derrick Holman, M.D., serves as the company's medical director, and its Scientific Advisory Board includes Dr. Bruce Hollis, Dr. Samantha Kimball and Dr. William Grant.

Media contact: contact@enyrgy.com, (888) 316-1695, enyrgy.com

Enyrgy is a wellness device and is not a medical device. Enyrgy does not diagnose, treat, cure or prevent any disease. Statements regarding the Enyrgy device have not been evaluated by the Food and Drug Administration.

SOURCE: Enyrgy Inc